Latest Breaking News On - Talk with your doctor about - Page 1 : comparemela.com

A recent Phase 3 trial showed people with radiologically isolated syndrome (RIS) who took Aubagio were 72 percent less likely to later develop MS symptoms.

United statesWinston salemNorth carolinaNew havenErin longbrakeChristine lebrun frenayLebrun frenayScott otallahAmerican academy of neurologyDrug administrationUniversity hospital of niceAtrium health wake forest baptistAmerican academyAnnual meetingUniversity hospitalTaking teriflunomide had